Reuters logo
6 months ago
BRIEF-Alnylam Pharmaceuticals reports fourth quarter and full year 2016 financial results and highlights recent period activity
February 8, 2017 / 9:11 PM / 6 months ago

BRIEF-Alnylam Pharmaceuticals reports fourth quarter and full year 2016 financial results and highlights recent period activity

Feb 8 (Reuters) - Alnylam Pharmaceuticals Inc

* Alnylam Pharmaceuticals reports fourth quarter and full year 2016 financial results and highlights recent period activity

* Q4 revenue $17.5 million versus $7.6 million

* Q4 revenue view $11 million -- Thomson Reuters I/B/E/S

* Alnylam Pharmaceuticals Inc says expects to end 2017 with greater than $700 million in cash

* Alnylam Pharmaceuticals Inc says also in early 2017, Alnylam plans to initiate ATLAS phase 3 program for fitusiran Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below